共 629 条
[21]
Luger SM(2015)Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols Cancer 121 3809-3749
[22]
Marks DI(2014)Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia Blood 123 3739-5207
[23]
McMillan AK(2009)IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report J Clin Oncol 27 5202-2306
[24]
Moorman AV(2016)Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665 Leuk Lymphoma 57 2298-110
[25]
Patel B(2007)Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia Eur J Haematol 78 102-252
[26]
Paietta E(2008)First European chemotherapy schedule for elderly patients with acute lymphoblastic leukemia: promising remission rate and feasible moderate dose intensity consolidation Blood 112 304-20
[27]
Tallman MS(2011)A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study Haematologica 96 245-6337
[28]
Goldstone AH(2012)Moderate intensive chemotherapy including CNS-prophylaxis with liposomal cytarabine is feasible and effective in older patients with Ph-negative acute lymphoblastic leukemia (ALL): results of a prospective trial from the German multicenter study Group for Adult ALL (GMALL) Blood 120 1493-1053
[29]
Rowe JM(2016)Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: results of three prospective parallel trials from the PETHEMA group Leuk Res 41 12-753
[30]
Buck G(2009)Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia Blood 113 6330-200